APA (7th ed.) Citation

M, E. F., AR, R., L, U., N, A., NM, G., LC, D., . . . AC, E. (2024). Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide. Theranostics, 14(12), 4701. https://doi.org/10.7150/thno.96641

Chicago Style (17th ed.) Citation

M, El Fakiri, et al. "Development and Preclinical Characterization of a Novel Radiotheranostic EphA2-targeting Bicyclic Peptide." Theranostics 14, no. 12 (2024): 4701. https://doi.org/10.7150/thno.96641.

MLA (9th ed.) Citation

M, El Fakiri, et al. "Development and Preclinical Characterization of a Novel Radiotheranostic EphA2-targeting Bicyclic Peptide." Theranostics, vol. 14, no. 12, 2024, p. 4701, https://doi.org/10.7150/thno.96641.